Published trade mark details for 2615983
This information was published on 2026-01-01T06:21:43 for IP Right Filed Published.
| Field | Value |
| (210) | 2615983 (IR 1894975) |
| (220) |
10 Oct 2025
|
| (300) |
CH, 14 Apr 2025, 831333
|
| (500) |
The cross in the trademark shall be reproduced neither in white on a red background nor in red on a white background; it will also not be reproduced in any other color likely to cause confusion with the Swiss Federal Cross or the emblem of the Red Cross
|
| (511) (510) |
Class 5
Pharmaceutical preparations; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of immunological disorders; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for the treatment of graft versus host disorder (GVHD); pharmaceutical preparations for the treatment of hematological disorders; pharmaceutical preparations for the treatment of hypophosphatemia disorders; pharmaceutical preparations for the treatment of myeloproliferative disorders; pharmaceutical preparations for the treatment of skeletal or chondrocyte disorders; pharmaceutical preparations for the treatment of dermatological disorders; pharmaceutical preparations for the treatment of fibrotic disorders; pharmaceutical preparations for the treatment of auto-immune disorders. Class 44 Providing medical information via a website; Providing medical information to healthcare providers and patients relating to oncological, viral, hematological, auto-immune, graft versus host, inflammatory, metabolic, myeloproliferative, skeletal or chondrocyte and dermatological disorders. |
| (540) |
|
| (550) | Figurative |
| (730) |
Incyte Holdings Corporation
|
Find out more about publications on the About page.